Abstract graphic of an eye
Investor Relations

Press Release

Harvard Apparatus Ltd. Acquires Clark Electromedical Instruments

September 6, 1999
Harvard Apparatus Ltd. Acquires Clark Electromedical Instruments

Harvard Apparatus, Inc. (HAI) of Holliston, Massachusetts announces the acquisition of Clark Electromedical Instruments by Harvard Apparatus Ltd. our UK subsidiary located in Edenbridge, England.

Clark Electromedical Instruments manufactures micro-pipettes and micro-electrodes used primarily in intracellular research. Additionally, Clark Electromedical Instruments is the European distributor for Warner Instruments Corporation and David Kopf Instruments.

Clark Electromedical will continue to trade under the Clark brand name, however, all manufacturing, marketing and sales support has been relocated to the Harvard Edenbridge facility. The Clark products will continue to be available through the Clark worldwide distribution network and will now be available through all of Harvard’s subsidiaries worldwide. We are pleased that Mr. Douglas Clark, the previous President of Clark Electromedical, will consult with Harvard for a period of up to three years.

The acquisition of Clark Electromedical Instruments strengthens our position in Cell Biology and complements the recently acquired Medical Systems product line.

For further information, please contact HAI; Chane Graziano, CEO or David Green, President at 800-272-2775.

The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.